CDC says the Bundibugyo virus outbreak in the DRC is the second-largest Ebola outbreak on record, with 9735 confirmed cases and 4690 deaths.
|Videos|July 21, 2020
Ebola Outbreak Reaches 60 Patients in Mbandaka, DRC
Author(s)Grant M. Gallagher
How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?
Advertisement
Another Ebola outbreak recently begun in the Democratic Republic of the Congo. How might this outbreak in Equateur Province differ from the recent outbreak in Kivu, a more conflict-prone region of the country?
Contagion spoke with Dr. Krutika Kuppalli and Dr. Jason Kindrachuk, experts in Ebola with experience working abroad.
Dr. Kindrachuk is a virologist who has done research on Ebola at labs within endemic countries. Kindrachuk also has experience in other emerging viruses, including coronaviruses. Dr. Kuppalli is an accomplished infectious disease physician.
Context Coverage:
New DRC Ebola Outbreak Emerging in Equateur Province
The 11th Ebola outbreak began in early June. This piece was published when there were 6 cases detected by public health authorites.
The World Health Organization (WHO) has shared reports from the Democratic Republic of the Congo indicating a new outbreak of Ebola virus is occurring in the nation’s northwest region. As of June 1, there have been at least 6 cases detected in Mbandaka, a port city with a population of more than 1.2 million people.
The years-long Ebola outbreak in the eastern province of North Kivu, which borders Lake Kivu, was exacerbated by political violence. The region also faces a wide array of unmet social needs, with challenges ranging from measles to malnutrition. The North Kivu outbreak has just begun to decline in recent months, after more than 2260 deaths, though it is still considered a Public Health Emergency of International concern by the WHO.
The initial 6 cases detected in the Wangata health zone led to 4 deaths. At least 2 other patients are still in care. Authorities expect more cases to be identified as contact tracing is performed.
Mbandaka was the epicenter of the country’s 9th Ebola outbreak, which lasted from May-July 2018. And it now appears to be the site of the nation’s 11th.
“Given the proximity of this new outbreak to busy transport routes and vulnerable neighboring countries we must act quickly,” Matshidiso Moeti, MBBS, WHO Regional Director for Africa said in a release.
WHO and various non-governmental organizations have a presence in Mbandaka, due to infrastructure built up in preceding pandemics. The existing team in Mbandaka aided in collection and testing of samples. There are 25 more WHO personnel slated to arrive in the city tomorrow.
Read the
Advertisement
Related to this article
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
As of October 15, CDC reports 9235 confirmed cases and 4444 deaths in the Bundibugyo virus Ebola outbreak in the DRC, now the second-largest on record.
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
The FDA approved bepirovirsen (Hibsago; GSK) with nucleos(t)ide analogue therapy for chronic hepatitis B, based on B-Well 1 and 2 functional cure rates of 19% vs 0% with placebo.
Projected disease burden from declining childhood vaccine coverage shows increases in vaccine-preventable diseases. Benjamin Lopman, PhD, provides insights on how VaxImpactMap works and the potential long-term disease consequences of decreased immunization rates.
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.
Advertisement
Advertisement
Trending on Contagion Live
1
Early Dual Therapy Shortens Staphylococcus aureus Bacteremia in SABEDTIO Trial
2
Ebola Update: DRC Outbreak Reaches 9735 Cases, Second Largest on Record
3
IDSA 2026 Guidance Makes Sulbactam-Durlobactam the Priority for CRAB Infections
4
ID Week Highlights Part 1
5